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Background: The main aim of this systematic review was to assess the dry socket management using plasma rich 
in growth factor (PRGF) in terms of pain relief, alveolar fossa healing, inflammation, the incidence of dry socket. 
Material and Methods: PubMed, Cochrane Library, Elsevier Science Direct, China Biology Medicine (CBM), 
China National Knowledge Infrastructure (CNKI) and VIP database were searched for the related articles without 
language limitation. Two reviewers independently searched and evaluated relevant studies. This review has been 
registered in the website PROSPERO (CRD42018087252). 
Results: 28 articles were retrieved on PubMed and 98 on other electronic databases in the initial search. In the end, 
4 randomized controlled trials (RCTs) were included, with a total of 139 patients enrolled. The descriptive results 
indicated that the use of PRGF may help reduce pain and inflammation after tooth extraction. To some extent, it is 
beneficial to the management of dry socket after extraction. 
Conclusions: Quality assessment indicated all the included studies were judged to be at high risk of bias with 
low quality. Hence, it was impossible to make a recommendation for clinical use of PRGF based on the current 
evidence. Clearly, a multicenter clinical randomized controlled trial is needed urgent to evaluate the safety and 
efficacy of PRGF for dry socket management.
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Introduction
The unscientific term “dry socket” also called alveolar os-
teitis, was first proposed by Crawford in 1896. Dry socket 
is characterized by an extraction alveolus lack of a blood 
clot and along with sudden intense, lancing and radiat-
ed pain after 2-3 days following tooth extraction in and 
around the extraction sites, accompanying strong smell of 
corruption (1-4). The most common findings in clinical 
examinations are the extraction sockets without any blood 
clots and sometimes part blood clots with spoilage and ne-
crosis in the extraction sockets (5). On account of the dif-
ferent diagnostic criteria used, the incidence of dry socket 
reported in the literature is inconsistent. It is reported that 
the incidence of dry socket is about 20%-35% after im-
pacted mandibular third molars extraction (2,6,7), whereas 
its occurrence for all extraction is from 3% to 5% (8,9). 
Patients infected with dry socket after extraction often 
seek urgent treatment for severe pain, halitosis and dys-
geusia (bad taste) (4). To date, various modalities were 
proposed for dry socket management. These treatments 
included topical using pain reducing dressing such as 
zinc oxide eugenol (ZOE) dressing (10-13) and chitosan 
dressing (14), topical or systemic antibiotics agents, and 
wound healing promoting drugs for example exogenous 
tretinoin acid (15), honey (16,17),herbal exacts (18). Sur-
gical debridement treatment for dry socket, refers to 
some or all of the following procedures: block anesthe-
sia for the socket, debridement, irrigation and placing a 
dressing with or without sutures (19). 
Autologous platelet concentrates (PCs) are being widely 
used in the field of dental and tissue regenerative medi-
cine (20-22). PRGF is a leukocyte-free, of standard 
composition and dosage, 100% autologous platelet-rich 
plasma (PRP) (23-25). However, PRGF is regarded as a 
secure and optimized product that avoids many of the 
limitations of using other PRPs (26). It has been report-
ed that PRGF has been displayed tissue regeneration in 
implant placement and the maxillary sinus membrane 
damage repair (27-31) and antibacterial activity (32,33) 
in a series of post-operations in oral surgery. 
There were conflicting results for the efficacy of PRGF 
used for dry socket management following the third mo-
lars extraction (12,26,34,35), due to small sample size, 
short follow-up and inconsistent outcome variables. 
The main aim of this systematic review was to assess 
the dry socket management using PRGF in terms of 
pain relief, alveolar fossa healing, inflammation, the in-
cidence of dry socket.
Material and Methods
This systematic review was performed in agreement 
with PRISMA statement guidelines (36). The protocol 
and methods used were registered in website PROSPE-
RO (CRD42018087252), which is an international pro-
spective register of systematic reviews.
- Search methods and key words
Systematic and comprehensive retrieval was carried 
out in the following electronic database: PubMed, Co-
chrane Library, Elsevier Science Direct, China Biology 
Medicine (CBM), China National Knowledge Infra-
structure (CNKI) and VIP database (Chinese scientific 
journal database). The search strategy on PubMed is as 
follows: (dry socket OR alveolar osteitis OR fibrinolytic 
alveolitis OR alveolitis sicca dolorosa OR localized os-
teomyelitis OR delayed extraction wound healing OR 
localized osteitis alveoli OR septic socket OR necrotiz-
ing socket OR tooth extraction* OR teeth extraction* 
OR dry socket [Mesh]) AND (plasma rich in growth 
factor* OR plasma rich growth factor* OR PRGF). In 
other electronic databases, the mesh terms search was 
not used.
In addition, a manual search was performed to find 
related articles in the following publications: British 
Journal of Oral and Maxillofacial Surgery, Internation-
al Journal of Oral and Maxillofacial Surgery, Journal 
of oral and maxillofacial surgery, Oral Surgery, Oral 
Medicine, Oral Pathology and Oral Radiology, Euro-
pean Journal of Dentistry, Journal of Dental Research, 
Journal of the American Dental Association, Australian 
Dental Journal, Oral and Maxillofacial Surgery, British 
Dental Journal, Oral Diseases, Indian Journal of Dental 
Research.
Besides, a manual search and screening of the referenc-
es reported in the studies identified was also comple-
mented. The above retrieval process was performed by 
two reviewers independently (XJL and LJT). An upper 
date limit of 26 March 2019 was applied, with no lower 
date limit. There was no language restriction.
Inclusion and exclusion criteria
Studies with the following characteristics were in-
cluded: 1-Population: studies of humans that included 
adult patients who had undergone extractions of one 
or more teeth; 2-Intervention: application of PRGF to 
post extraction sockets; 3-Comparison: application of a 
placebo or other treatments to post extraction sockets; 
4-Outcome: pain relief, alveolar fossa healing, inflam-
mation, the incidence of dry socket; 5-Study design: 
only randomized clinical trials (RCTs) were included, 
with the other factors matched between the groups. 
Exclusion criteria: 1-reviews, editorials, case reports, 
letters and conference abstracts; 2-animals studies were 
excluded; 3-studies without control group were exclud-
ed.
- Data extraction   
The data from all included studies were extracted in-
dependently by two reviews (XJL and LJT) using pre-
defined data extraction form. The following informa-
tion was extracted from each study (when available): 
first author, publication year, location, design method, 
characteristics of population, smoking status, oral con-
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traceptive administration, extraction sites, intervention 
characteristics, follow-up period, outcome measures.
- Quality assessment
The methodological quality of all selected studies were 
evaluated independently by two reviewers (XJL and 
LJT), and these were cross-checked. Disagreements 
between the two reviewers were resolved by consensus 
with a third reviewer (XR). Quality assessment tool for 
randomized controlled trials was on the basis of the risk 
of bias assessment scale recommended in the Cochrane 
handbook for systematic reviews. The classification of 
the risk of bias potential was based on the following 
criteria: sequence generation, allocation concealment, 
blinding of participants and personnel, blinding of out-
come assessment, incomplete outcome data addressed, 
selective reporting, and other sources of bias. If all as-
sessment items are reported as ‘yes’, the study is judged 
to be at low risk of bias. If one or more items are report-
ed as ‘unclear’, the study is considered to be at moderate 
risk of bias. If one or more items are reported as ‘no’, the 




126 titles were retrieved in the initial search. All the 
titles were poured into the professional document man-
agement NoteExpress (a Chinese software similar to 
EndNote, http://lib.ahmu.edu.cn/). Its duplicate check-
ing function excluded 8 titles. After duplicate removal, 
118 titles were screened by title and abstract, leading 
to 94 titles excluded. Moreover, 24 potentially eligible 
titles were retrieved through the consulting of reference 
lists of included studies. Finally, only 4 articles were 
included for the qualitative synthesis (Fig. 1).
- Characteristics of all the included studies
Basic details of all the selected studies were shown in 
Table 1. All the four studies were RCTs, two of which 
adopted split-mouth design. A total of 139 patients were 
enrolled in the four studies. The duration of the study 
was 8 years, from 2010 to 2018. Two studies were car-
ried out in Europe (UK, Italy), one in India and the other 
in Iran. Two studies included smokers, but did not detail 
the smoking status. Only one study included women 
taking oral contraceptives. Not every article provided 
information about the number of sockets and the extrac-
tion sites. The follow-up periods varied among the four 
articles, with the shortest of one day and the longest of 
15 days. All clinical outcome measures in four studies 
comprised pain relief and healing situation.
- Quality assessment
Every study was evaluated for potential risk of bias. The 
results of the quality assessment of all the four stud-
ies was presented in Table 2. Unfortunately, all includ-
ed studies were judged to be at high risk of bias with 
low quality. Kappa statistic value for the inter-reviewer 
agreement was 0.851, which indicates “almost perfect” 
based on Landis and Koch scale (37).
- Quantitative synthesis
The results of studies included for analysis were pre-
sented in Table 3. This systematic review did an attempt 
to conduct a meta-analysis by virtue of STATA 12.0 
software, which could summarize the extracted data 
from the included studies, enhancing statistical power. 
However, based on the above fact that too small sample, 
low-quality literature and high heterogeneity among the 
four studies, a meta-analysis was considered to be inap-
propriate here. 
- Qualitative description 
Pain relief
VAS scores system of 10 cm was used for evaluation of 
pain level in all included studies. Mozzati et al. found 
that the pain level was lower for PRGF sites than for 
control sites at all times examined (1d to 7d), however, 
this difference was statistically significant only at 7d 
with p value of <0.05. Haraji et al. reported that the in-
tensity of post-extraction pain in PRGF group was sig-
nificantly less than that in control group with p value of 
< 0.00 at each post-extraction day (2d, 3d, 4d). Pal et al. 
noted that pain reduction level is more rapid in zinc ox-
ide eugenol group than in PRGF group and saline irri-
gation group at 1d, 2d, 3d, 7d (p<0.001), but the change 
is no significant at 15d in all the groups. Contrary to 
the above, King et al. indicated that there were not sta-
tistically significant for the pain level between PRGF 
and Alvogyl® group at 3d and 7d, even though the VAS 
value of the PRGF group was low. 
Fig. 1: PRISMA flow chart of the search strategy.
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Table 1: Characteristics of all the selected studies.
Author Mozzati et al. Haraji et al. Pal et al. King et al.
Publication year 2010 2012 2013 2018
Location Italy Iran India UK
Design method RCT,SM RCT, SM RCT RCT
Number of patients 16 40 45 38
Number of sockets 32 80 NM 44
Mean age (range), 













Smoking population NM 18 patients Excluded 13 patients
OC administration NM 10 patients NM NM
Extraction sites Mandibular third molar 
Maxillary or mandibu-
lar third molar 






G1: PRGF with gelatin 
sponge




Follow-up 1,2,3,4,5,6 and 7days 2, 3, 4 and 7 days 1,2,3,7 and 15 days 3 and 7 days




bone, halitosis, dysgeusia 
RCT=randomized controlled trial; SM=split-mouth; DS=dry socket; NM=not mentioned; OC=oral contraceptive; G1= test group; G2=control 


























risk of bias 
Mozzati et al. Unclear No No No Unclear Yes Yes High
Haraji et al. Unclear No Yes No Unclear Yes Yes High
Pal et al. Unclear No Unclear No Unclear Yes Yes High
King et al. Yes Yes No Yes Yes Yes Yes High
Table 2: Results of quality assessment.
Author Mozzati et al. Haraji et al. Pal et al. King et al.



















































Table 3: Results of studies included for analysis.
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Exposed bone (% 


























Incidence of dry 
socket NE
4 cases in G1
18 cases in G2
p<0.05
NE NE
VAS=visual analogue scale; (#)=the data was estimated from the figure; NE=not evaluated; G1,G2,G3= illustration same as Table 1.
Table 3 cont: Results of studies included for analysis.
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Alveolar fossa healing
During the 7d follow-up periods, Haraji et al. and Pal et 
al. found that the healing of the PRGF group was faster 
than that of the corresponding control group with p val-
ue <0.001. However, no statistical difference was found 
in the study by King et al. As the postoperative time 
was prolonged to 15d, the Pal et al reported there is no 
difference in healing values between groups. 
Inflammation
King et al. indicated that at 7d clinical inflammation 
was significantly lower in patients in the PRGF® group 
compared to the Alvogyl® group. Whereas these differ-
ences were not significant at 3d.
The incidence of dry socket
Haraji et al. evaluated the incidence of dry socket. In 
the control group, 18 patients presented dry socket. Four 
patients developed dry socket in PRGF group. This was 
indicative of a statistically significant difference when 
PRGF was used (p<0.05).
Discussion
PRGF was used in various types of surgery in oral and 
maxillofacial surgery. These procedures included se-
ries of complicated surgery such as the tooth extraction 
socket filling (38-40), maxillary sinus augmentation 
(41), and maxillofacial bone defects (42,43). It has been 
reported that the use of PRGF can reduce postoperative 
pain and inflammatory response, accelerate epithelial 
formation of soft tissue and promote regeneration of 
bone tissue (44,45). 
The purpose of this review is to evaluate the efficacy 
of PRGF used in the dry socket management following 
the third molars extraction, further to provide scien-
tific evidence for clinical applications. Although many 
scholars praised the benefits of PRGF clinical applica-
tion in many fields, few clinical trials have been con-
ducted to investigate the effect of PRGF on dry socket 
treatment after tooth extractions, especially random-
ized controlled trials. Four randomized controlled tri-
als (12,26,34,35) on this topic was retrieved into this 
review, of which only one article meet the high quality 
(35) standards of the modified Jadad scale (36) and the 
remaining three (12,26,34) were low quality. In addi-
tion, obvious heterogeneity were found in the method 
adopted and outcome variables used in the process of 
evaluation of the healing of dry socket. A quantitative 
meta-analysis cannot be performed in this case and we 
could only do a qualitatively descriptive study on the 
subject.
One possible factor amongst many confounding factors 
in this systematic review is the choice of indications for 
extraction. If the teeth were extracted for different rea-
sons such as impact, trauma, periodontitis or periapi-
cal infection, the healing process may be different. A 
histological study (46), conducted for nearly two years, 
found that the speed of bone formation in the diseased 
sockets were more slowly than that in the disease-free 
sockets. New bone area exceeded 50% of the total new-
ly regenerated tissue in the infected sockets after 16 
weeks, whereas new bone area in the disease-free sock-
ets exceeded 50% of the total tissue. However, a retro-
spective chart review by Bell et al. (47) demonstrated 
that clinical attempt to place implant in the extraction 
socket in the presence of chronic apical periodontitis 
can be regarded as a safe and feasible treatment option. 
It is well known that the healing of the impacted third 
molars with soft tissue resistance would be better than 
that with bone tissue resistance. 
Another confounding factor could be the types of pro-
tocol for acquiring PRGF preparations among different 
studies. Currently, there are many different methods 
proposed for the preparation of PRGF products. The 
core aim of different technique used to obtain PRGF 
was to produce a leukocyte-free preparation so as to re-
duce the content of pro-inflammatory cytokines. Some 
of the four included studies did not provide a detailed 
description of a series of parameters involving in the 
PRGF production preparation process (cell separators 
used, centrifugation methods, blood volume collected 
before surgery, collected the platelet baseline concen-
tration, the amount of platelet concentrate obtained, the 
final increase in platelet concentration, the type of blood 
anticoagulant and platelet activator used). Any of these 
factors may play a role in the vitality and activity of the 
tissue. Different concentrations and levels of PRGF may 
have different biological properties.
There are some limitations for this systematic review: 
1- the search process led to the inclusion of only four 
articles, the number of which was too small. In addition, 
the number of patients included in the study was small, 
result of which may be partial bias. 2- the included stud-
ies did not perform well in random sequences genera-
tion, allocation concealment and blinded methods, as 
these are important for RCTs. Furthermore, there was 
no multicenter randomized controlled studies. 3- there 
are no specific diagnostic criteria for dry socket in 
these studies. 4- oral contraceptive use (48) and tobacco 
smoking (49) may influence the incidence of dry socket, 
but he included studies did not handle these two con-
founding factors.   
In summary, meta-analysis cannot be performed given 
the heterogeneity of the outcome variables included in 
the different studies. According to results from selected 
studies, the use of PRGF may help reduce pain and in-
flammation after tooth extraction, thereby improving 
the quality of life of patients after tooth extraction. How-
ever, after evaluating quality of the included articles, we 
found that the evidence quality of PRGF applied to the 
dry socket management after the third tooth extractions 
was poor, so it was impossible to make a recommen-
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dation for clinical use of PRGF. Clearly, a multicenter 
clinical randomized controlled trial is needed to urgent 
conduct to evaluate the safety and efficacy of PRGF for 
dry socket management after mandibular third molar 
extraction.
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